{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T01:00:37Z","timestamp":1788397237867,"version":"build-2803163510"},"reference-count":31,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","gynecologiconcology-online.net","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Gynecologic Oncology"],"published-print":{"date-parts":[[2021,1]]},"DOI":"10.1016\/j.ygyno.2020.10.028","type":"journal-article","created":{"date-parts":[[2020,11,6]],"date-time":"2020-11-06T22:03:52Z","timestamp":1604700232000},"page":"56-63","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":58,"title":["Is there any therapeutic role of pelvic and para-aortic lymphadenectomy in apparent early stage epithelial ovarian cancer?"],"prefix":"10.1016","volume":"160","author":[{"given":"Nicol\u00f2","family":"Bizzarri","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andreas","family":"du Bois","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert","family":"Fruscio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesca","family":"De Felice","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pierandrea","family":"De Iaco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jvan","family":"Casarin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Enrico","family":"Vizza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vito","family":"Chiantera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giacomo","family":"Corrado","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefano","family":"Cianci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sonia","family":"Magni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Debora","family":"Ferrari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniela","family":"Giuliani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philipp","family":"Harter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beyhan","family":"Ataseven","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mareike","family":"Bommert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna Myriam","family":"Perrone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giovanni","family":"Scambia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Fagotti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"6","key":"10.1016\/j.ygyno.2020.10.028_bb0005","first-page":"394","article-title":"Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"68","author":"Bray","year":"2018","journal-title":"CA Cancer J. Clin."},{"issue":"4","key":"10.1016\/j.ygyno.2020.10.028_bb0010","first-page":"284","article-title":"Ovarian cancer statistics, 2018","volume":"68","author":"Torre","year":"2018","journal-title":"CA Cancer J. Clin."},{"issue":"7","key":"10.1016\/j.ygyno.2020.10.028_bb0015","doi-asserted-by":"crossref","first-page":"2053","DOI":"10.1245\/s10434-018-6412-y","article-title":"Stage- and histologic subtype-dependent frequency of lymph node metastases in patients with epithelial ovarian Cancer undergoing systematic pelvic and Paraaortic lymphadenectomy","volume":"25","author":"Heitz","year":"2018","journal-title":"Ann. Surg. Oncol."},{"issue":"1","key":"10.1016\/j.ygyno.2020.10.028_bb0020","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ijgo.2013.10.001","article-title":"FIGO committee on gynecologic oncology. Staging classification for cancer of the ovary, fallopian tube, and peritoneum","volume":"124","author":"Prat","year":"2014","journal-title":"Int. J. Gynaecol. Obstet."},{"issue":"3","key":"10.1016\/j.ygyno.2020.10.028_bb0025","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1016\/j.ygyno.2011.05.001","article-title":"Risk factors for lymph node metastasis in apparent early-stage epithelial ovarian cancer: implications for surgical staging","volume":"122","author":"Powless","year":"2011","journal-title":"Gynecol. Oncol."},{"issue":"3","key":"10.1016\/j.ygyno.2020.10.028_bb0030","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1016\/j.ygyno.2011.09.013","article-title":"Lymph node metastasis in stages I and II ovarian cancer: a review","volume":"123","author":"Kleppe","year":"2011","journal-title":"Gynecol. Oncol."},{"issue":"5","key":"10.1016\/j.ygyno.2020.10.028_bb0035","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1093\/annonc\/mdz062","article-title":"ESMO-ESGO consensus conference recommendations on ovarian cancer: pathology and molecular biology, early and advanced stages, borderline tumours and recurrent disease","volume":"30","author":"Colombo","year":"2019","journal-title":"Ann. Oncol."},{"issue":"1","key":"10.1016\/j.ygyno.2020.10.028_bb0040","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1097\/COC.0b013e318134ee6f","article-title":"For women receiving chemotherapy for clinically apparent early ovarian cancer, is there a benefit to surgical staging?","volume":"31","author":"Dizon","year":"2008","journal-title":"Am. J. Clin. Oncol."},{"issue":"1","key":"10.1016\/j.ygyno.2020.10.028_bb0045","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1097\/01.AOG.0000249610.95885.ef","article-title":"Association of lymphadenectomy and survival in stage I ovarian cancer patients","volume":"109","author":"Chan","year":"2007","journal-title":"Obstet. Gynecol."},{"issue":"5","key":"10.1016\/j.ygyno.2020.10.028_bb0050","doi-asserted-by":"crossref","DOI":"10.3802\/jgo.2018.29.e69","article-title":"Adequate pelvic lymphadenectomy and survival of women with early-stage epithelial ovarian cancer","volume":"29","author":"Matsuo","year":"2018","journal-title":"J. Gynecol. Oncol."},{"issue":"6","key":"10.1016\/j.ygyno.2020.10.028_bb0055","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1007\/s10147-012-0483-8","article-title":"Clinical impact of systematic pelvic and Para-aortic lymphadenectomy for pT1 and pT2 ovarian cancer: a retrospective survey by the Sankai gynecology study group","volume":"18","author":"Oshita","year":"2013","journal-title":"Int. J. Clin. Oncol."},{"key":"10.1016\/j.ygyno.2020.10.028_bb0060","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.ejca.2016.07.015","article-title":"The impact of lymph node dissection and adjuvant chemotherapy on survival: a nationwide cohort study of patients with clinical early-stage ovarian cancer","volume":"66","author":"Kleppe","year":"2016","journal-title":"Eur. J. Cancer"},{"issue":"6","key":"10.1016\/j.ygyno.2020.10.028_bb0065","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1038\/sj.bjc.6603323","article-title":"Randomised study of systematic lymphadenectomy in patients with epithelial ovarian cancer macroscopically confined to the pelvis","volume":"95","author":"Maggioni","year":"2006","journal-title":"Br. J. Cancer"},{"issue":"2","key":"10.1016\/j.ygyno.2020.10.028_bb0070","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/j.ijgo.2007.11.004","article-title":"History of the FIGO cancer staging system","volume":"101","author":"Odicino","year":"2008","journal-title":"Int. J. Gynaecol. Obstet."},{"issue":"3","key":"10.1016\/j.ygyno.2020.10.028_bb0075","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1016\/j.ygyno.2006.06.013","article-title":"Randomized phase III trial of three versus six cycles of adjuvant carboplatin and paclitaxel in early stage epithelial ovarian carcinoma: a gynecologic oncology group study","volume":"102","author":"Bell","year":"2006","journal-title":"Gynecol. Oncol."},{"issue":"3","key":"10.1016\/j.ygyno.2020.10.028_bb0080","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/j.ygyno.2009.10.073","article-title":"The potential benefit of 6 vs. 3 cycles of chemotherapy in subsets of women with early-stage high-risk epithelial ovarian cancer: an exploratory analysis of a gynecologic oncology group study","volume":"116","author":"Chan","year":"2010","journal-title":"Gynecol. Oncol."},{"issue":"2","key":"10.1016\/j.ygyno.2020.10.028_bb0085","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1016\/j.ygyno.2016.12.004","article-title":"Three versus six cycles of adjuvant platinum-based chemotherapy in early stage clear cell ovarian carcinoma - a multi-institutional cohort","volume":"144","author":"Prendergast","year":"2017","journal-title":"Gynecol. Oncol."},{"issue":"7","key":"10.1016\/j.ygyno.2020.10.028_bb0090","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.1111\/IGC.0b013e3181efd843","article-title":"Is there a high- risk subgroup of stage I epithelial ovarian cancer that is most likely to benefit from 6 versus 3 cycles of adjuvant chemotherapy?","volume":"20","author":"Bakkum-Gamez","year":"2010","journal-title":"Int. J. Gynecol. Cancer"},{"key":"10.1016\/j.ygyno.2020.10.028_bb0100","doi-asserted-by":"crossref","DOI":"10.1097\/01.sla.0000133083.54934.ae","article-title":"Classification of surgical complications: a new proposal with evaluation in a cohort of 6336 patients and results of a survey","volume":"240","author":"Dindo","year":"2004","journal-title":"Ann. Surg."},{"key":"10.1016\/j.ygyno.2020.10.028_bb0105","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1080\/01621459.1958.10501452","article-title":"Nonparametric estimation from incomplete observation","volume":"53","author":"Kaplan","year":"1958","journal-title":"J. Am. Stat. Assoc."},{"key":"10.1016\/j.ygyno.2020.10.028_bb0110","first-page":"163","article-title":"Evaluation of survival data and two new rank order statistics arising in its consideration","volume":"50","author":"Mantel","year":"1966","journal-title":"Cancer Chemother. Rep."},{"issue":"10","key":"10.1016\/j.ygyno.2020.10.028_bb0115","doi-asserted-by":"crossref","first-page":"2202","DOI":"10.1002\/cncr.23390","article-title":"Prognostic factors for high-risk early-stage epithelial ovarian cancer: a gynecologic oncology group study","volume":"112","author":"Chan","year":"2008","journal-title":"Cancer."},{"issue":"4","key":"10.1016\/j.ygyno.2020.10.028_bb0120","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1592\/phco.21.5.405.34503","article-title":"Post hoc power analysis: an idea whose time has passed?","volume":"21","author":"Levine","year":"2001","journal-title":"Pharmacotherapy."},{"issue":"2","key":"10.1016\/j.ygyno.2020.10.028_bb0125","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1093\/jnci\/95.2.125","article-title":"International collaborative ovarian neoplasm trial 1: a randomized trial of adjuvant chemotherapy in women with early-stage ovarian cancer","volume":"95","author":"Colombo","year":"2003","journal-title":"J. Natl. Cancer Inst."},{"issue":"2","key":"10.1016\/j.ygyno.2020.10.028_bb0130","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1093\/jnci\/95.2.113","article-title":"Impact of adjuvant chemotherapy and surgical staging in early-stage ovarian carcinoma: European organisation for research and treatment of cancer-adjuvant chemotherapy in ovarian neoplasm trial","volume":"95","author":"Trimbos","year":"2003","journal-title":"J. Natl. Cancer Inst."},{"issue":"Suppl. 2","key":"10.1016\/j.ygyno.2020.10.028_bb0135","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1136\/ijgc-00009577-200311001-00002","article-title":"What have we learned from ICON1 and ACTION?","volume":"13","author":"Colombo","year":"2003","journal-title":"Int. J. Gynecol. Cancer"},{"issue":"9","key":"10.1016\/j.ygyno.2020.10.028_bb0140","doi-asserted-by":"crossref","first-page":"1274","DOI":"10.1016\/S1470-2045(17)30469-2","article-title":"Olaparib tablets as maintenance therapy in patients with platinum-sensitive, relapsed ovarian cancer and a BRCA1\/2 mutation (SOLO2\/ENGOT-Ov21): a double-blind, randomised, placebo-controlled, phase 3 trial","volume":"18","author":"Pujade-Lauraine","year":"2017","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.ygyno.2020.10.028_bb0145","series-title":"Randomized Controlled Phase III Study Evaluating the Impact of Secondary Cytoreductive Surgery in Recurrent Ovarian Cancer: Final Analysis of AGO DESKTOP III\/ENGOT ov20. 38, no. 15_suppl (May 20, 2020) 6000\u20136000","author":"Du Bois","year":"2020"},{"issue":"4","key":"10.1016\/j.ygyno.2020.10.028_bb0150","doi-asserted-by":"crossref","DOI":"10.1016\/j.ajog.2019.05.005","article-title":"Sentinel-node biopsy in early-stage ovarian cancer: preliminary results of a prospective multicentre study (SELLY)","volume":"221","author":"Uccella","year":"2019","journal-title":"Am. J. Obstet. Gynecol."},{"issue":"9","key":"10.1016\/j.ygyno.2020.10.028_bb0155","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1056\/NEJMoa1808424","article-title":"A randomized trial of lymphadenectomy in patients with advanced ovarian neoplasms","volume":"380","author":"Harter","year":"2019","journal-title":"N. Engl. J. Med."},{"issue":"6","key":"10.1016\/j.ygyno.2020.10.028_bb0160","doi-asserted-by":"crossref","first-page":"1234","DOI":"10.1002\/cncr.24149","volume":"115","author":"Du Bois","year":"2009","journal-title":"Cancer."}],"container-title":["Gynecologic Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090825820340506?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090825820340506?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,25]],"date-time":"2025-09-25T03:57:38Z","timestamp":1758772658000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0090825820340506"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,1]]},"references-count":31,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,1]]}},"alternative-id":["S0090825820340506"],"URL":"https:\/\/doi.org\/10.1016\/j.ygyno.2020.10.028","relation":{},"ISSN":["0090-8258"],"issn-type":[{"value":"0090-8258","type":"print"}],"subject":[],"published":{"date-parts":[[2021,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Is there any therapeutic role of pelvic and para-aortic lymphadenectomy in apparent early stage epithelial ovarian cancer?","name":"articletitle","label":"Article Title"},{"value":"Gynecologic Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ygyno.2020.10.028","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}